AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
There's a new skincare treatment out in the market today that targets skin blemishes with the efficacy of - but with none of the adverse reactions observed in - products containing Hydroquinone.
Before Germed Pharma's Unitone Intensive skin treatment was introduced in the market, people suffering from abnormal pigmentation relied on depigmenting agents with varying side effects. In the December 1999 issue of Medical Observer, some of the treatments listed included mercury salts, phenol derivatives (under which falls Hydroquinone), reducing agents, AHA or alpha hydroxy acids, ascorbic acid and acetylsalicylic acid.
The article found fault with the different …